register

Market Research & Insights

Impact of COVID-19 pandemic on medical devices market

Health Industry Hub | April 27, 2020 |

Market Research & Insights: The COVID-19 pandemic is leading to significant growth in demand for medical devices such as ventilators, medical clothing, face masks, and diagnostic devices such as test kits, whereas the revenue of companies, whose products rely heavily on elective and non-essential procedures, are expected to be impacted negatively.

Many medical device companies have revised their financial guidance for 2020 due to the uncertainty associated with the degree and duration of the impact of the outbreak.

The short-term impact of COVID-19 is expected to cause a decline in annual growth rate of the global medical devices market from 5.4% to 3.0% in 2020. The global medical devices market, which was projected to be worth USD 472 billion in 2020 before the COVID-19 outbreak, is now expected to generate USD 461 billion this year.

Customer engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content with high engagement and 20+ years industry experience. Created by industry for industry. Contact us.

Key Reasons for the Impact

Delay in Elective Surgery

Elective procedures have been delayed as countries divert their healthcare resources to contain the COVID-19 pandemic.

The impact of the delay in elective procedures on the demand for medical devices is significant as these types of procedures account for around 40% – 50% of the hospital’s revenues in some countries.

Supply Chain Disruptions

The supply of medical devices or the raw material required for the manufacturing of medical devices have been disrupted as many countries went into lock-down. The forced quarantine in China hit the supply-chain the hardest as the country transitioned from being a key player in the manufacturing of low-end to high-end medical devices.

With a significant increase in the demand for certain medical devices, some countries halted exports, especially the devices that are vital in fighting against the COVID-19 outbreak.

Impact of China

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

China, which accounted for around 7% of the global medical devices market, was projected to grow at a CAGR of around 10% in the 2018 – 2025 period before the outbreak. The demand for medical devices is expected to decline considerably in the first quarter of 2020 in China and impact the revenues of all major medical device companies.

Segments with Low Level Exposure to COVID-19

  • In-vitro Diagnostics
  • Diagnostic Imaging
  • Respiratory Care
  • General Hospital and Healthcare Supplies

Segments with High Level Exposure to COVID-19

  • Orthopaedic Devices
  • Cardiovascular Devices
  • Minimally Invasive Surgical Devices
  • Dental Equipment and Devices
  • Diabetes Care Devices
  • Ophthalmic Devices

Human Resources

Merck puts the 'family' in workplace as fertility survey exposes gaps

Merck puts the ‘family’ in workplace as fertility survey exposes gaps

Health Industry Hub | September 16, 2026 |

Merck has announced the results of its Fertility Futures Survey of 1,500 Australians aged 18 to 35, revealing significant gaps […]

More


News - MedTech & Diagnostics

Australia has a new genomics framework. But will patients see the difference?

Australia has a new genomics framework. But will patients see the difference?

Health Industry Hub | September 16, 2026 |

The government has released the National Health Genomics Policy Framework and Implementation Plan 2026–2030, jointly developed by the federal and […]

More


News - Pharmaceuticals

PCFA condemns funding axe and demands Prime Minister intervene

PCFA condemns funding axe and demands Prime Minister intervene

Health Industry Hub | September 16, 2026 |

The Prostate Cancer Foundation of Australia (PCFA) has condemned the Albanese Government’s decision to end funding for its national Prostate […]

More


News - Pharmaceuticals

Sanofi’s clinical-trial push hits a GP reality check

Sanofi’s clinical-trial push hits a GP reality check

Health Industry Hub | September 16, 2026 |

New research from Sanofi presented at the Australian Public Health Conference this week points to an addressable opportunity to increase […]

More


This content is copyright protected. Please subscribe to gain access.